Lymphoma in cardiac allotransplant recipients. Clinical and histological features and immunological phenotype.
To characterize further lymphomas which arise in chronically immunosuppressed allotransplant patients, we studied the clinical and histological features of seven cases of nonHodgkin's lymphoma and determined the immunological phenotype in four cases, which developed in a series of 182 patients who underwent cardiac transplantation at Stanford University Hospital. Clinical features which were correlated with the development of lymphoma included patient age, pretransplant diagnosis, and the number of transplants. All cases of nonHodgkin's lymphoma presented as solitary or multiple localized extranodal lesions while none presented in lymph nodes. Extranodal sites of involvement included brain, lung, and soft tissues of the thigh at the site of antilymphocyte serum injections. Histologically, five of seven lymphomas were classified as high grade, large cell, immunoblastic and two of seven as intermediate grade, large noncleaved cell. The immunological phenotype of the neoplasm from four patients was determined by reaction with immunoglobulin light and heavy chain reagents and monoclonal antibodies to T cell and B cell antigens. All lymphomas from four patients which were tested stained for Ia antigen (HLA-DR) but did not stain for immunoglobulin or the T cell antigens detected in this study.
D000008:Abdominal Neoplasms / Q000209:etiology / Q000276:immunology / Q000473:pathology; D000293:Adolescent; D000328:Adult; D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000209:etiology / Q000276:immunology / Q000473:pathology; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000209:etiology / Q000276:immunology / Q000473:pathology; D008223:Lymphoma / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D008297:Male; D011817:Rabbits; D013601:T-Lymphocytes / Q000276:immunology; D013899:Thoracic Neoplasms / Q000209:etiology / Q000276:immunology / Q000473:pathology
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents